Back
Bio-Path Holdings Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
13
BPTH
Bio-Path Holdings
Last Price:
0.79
Seasonality Move:
-1.41%
Sell
30
NBY
NovaBay Pharmaceuticals
Last Price:
0.69
Seasonality Move:
-0.57%
Sell
13
Bio-Path Holdings (BPTH)
is a Sell
Is Bio-Path Holdings a Buy, Sell or Hold?
- The current Bio-Path Holdings [BPTH] share price is $0.80. The Score for BPTH is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
- BPTH is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
30
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.72. The Score for NBY is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BPTH Stock Price Chart
What is Bio-Path Holdings's stock price today?
-
The Bio-Path Holdings share price today is $0.80
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BPTH is experiencing slight buying pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.72
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
BPTH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 37.75 | Sell |
Chaikin Money Flow: | 4772 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.84 - 1.06) | Sell |
Bollinger Bands (100): | (0.87 - 1.57) | Sell |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 54.51 | Buy |
Chaikin Money Flow: | 23717 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.61 - 0.75) | Buy |
Bollinger Bands (100): | (0.27 - 1.45) | Sell |
BPTH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.83 | Sell |
20-day SMA: | 0.91 | Sell |
50-day SMA: | 0.97 | Sell |
200-day SMA: | 2.62 | Sell |
8-day EMA: | 0.82 | Sell |
20-day EMA: | 0.89 | Sell |
50-day EMA: | 1.02 | Sell |
200-day EMA: | 3.88 | Sell |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.72 | Sell |
20-day SMA: | 0.7 | Buy |
50-day SMA: | 0.66 | Buy |
200-day SMA: | 2.35 | Sell |
8-day EMA: | 0.71 | Buy |
20-day EMA: | 0.7 | Buy |
50-day EMA: | 0.73 | Sell |
200-day EMA: | 5.62 | Sell |
Bio-Path Holdings Earnings Growth & BPTH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.23 per share, and an increase next year of $1.62 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.
Bio-Path Holdings Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |